Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas

Brain Research

Volumn 1257, Issue , 2009, Pages 25-31

  Marco, Eva María ^a,b   Rubino, Tiziana ^c   Adriani, Walter ^a   Viveros, María Paz ^b   Parolaro, Daniela ^c   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Adolescence; Anandamide; Developmental vulnerability; Endocannabinoid; FAAH; Long lasting effect; Rat

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABIS; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENDOCANNABINOID; AMIDE; ARACHIDONIC ACID DERIVATIVE; BENZAMIDE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CYCLOHEXYL CARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; CYCLOHEXYL CARBAMIC ACID 3'-CARBAMOYLBIPHENYL-3-YL ESTER;

ADOLESCENCE; ADOLESCENT; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HIPPOCAMPUS; HYDROLYSIS; LOCUS CERULEUS; MALE; MATURATION; NERVE CELL MEMBRANE POTENTIAL; NEUROBIOLOGY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; RECEPTOR BINDING; REPEATED DRUG DOSE; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM; AGING; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; GROWTH, DEVELOPMENT AND AGING; METABOLISM; WISTAR RAT;

CANNABIS; RATTUS;

AGING; ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONIC ACIDS; AUTORADIOGRAPHY; BENZAMIDES; BRAIN; CARBAMATES; MALE; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

EID: 63349104171     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.12.037     Document Type: Article

References (58)

1. Adams, I.B., Compton, D.R., Martin, B.R., 1998. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J. Pharmacol. Exp. Ther. 284, 1209-1217.
2. Adriani, W., Laviola, G., 2004. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav. Pharmacol. 15, 341-352.
3. Baker, D., Pryce, G., Davies, W.L., Hiley, C.R., 2006. In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol. Sci. 27, 1-4.
4. Beltramo, M., Bernardini, N., Bertorelli, R., Campanella, M., Nicolussi, E., Fredduzzi, S., Reggiani, A., 2006. CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur. J. Neurosci. 23, 1530-1538.
5. Belue, R.C., Howlett, A.C., Westlake, T.M., Hutchings, D.E., 1995. The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol. Teratol. 17, 25-30.
6. Biscaia, M., Marín, S., Fernández, B., Marco, E., Rubio, M., Guaza, C., Ambrosio, E., Viveros, M.P., 2003. Chronic treatment with CP 55,940 during the periadolescent period differentially affects the behavioural responses of male and female rats in the adulthood. Psychopharmacology 170, 301-308.
7. Bortolato, M., Mangieri, R.A., Fu, J., Kim, J.H., Arguello, O., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Piomelli, D., 2007. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol. Psychiatry 62, 1103-1110.
8. Chambers, R.A., Taylor, J.R., Potenza, M.N., 2003. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am. J. Psychiatry 160, 1041-1052.
9. Chevaleyre, V., Takahashi, K.A., Castillo, P.E., 2006. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 29, 37-76.
10. Cirulli, F., Laviola, G., 2000. Paradoxical effects of D-amphetamine in infant and adolescent mice: role of gender and environmental risk factors. Neurosci. Biobehav. Rev. 24, 73-84.
11. Dinh, T.P., Carpenter, D., Leslie, F.M., Freund, T.F., Katona, I., Sensi, S.L., Kathuria, S., Piomelli, D., 2002. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U. S. A. 99, 10819-10824.
12. Edwards, D.A., Zhang, L., Alger, B.E., 2008. Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus. Proc. Natl. Acad. Sci. U. S. A. 105, 8142-8147.
13. Ellgren, M., Spano, S.M., Hurd, Y.L., 2007. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology 32, 607-615.
14. Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Piomelli, D., 2005. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J. Pharmacol. Exp. Ther. 313, 352-358.
15. Fernandez-Ruiz, J., Gomez, M., Hernandez, M., de Miguel, R., Ramos, J.A., 2004. Cannabinoids and gene expression during brain development. Neurotox. Res. 6, 389-401.
16. Freund, T.F., Katona, I., Piomelli, D., 2003. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83, 1017-1066.
17. Gobbi, G., Bambico, F.R., Mangieri, R., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M.G., Debonnel, G., Duranti, A., Tontini, A., Tarzia, G., Mor, M., Trezza, V., Goldberg, S.R., Cuomo, V., Piomelli, D., 2005. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 102, 18620-18625.
18. Guiard, B.P., El Mansari, M., Blier, P., 2008. Crosstalk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus coeruleus, and dorsal hippocampus. Mol Pharmacol. 74, 1463-1475.
19. Harkany, T., Guzman, M., Galve-Roperh, I., Berghuis, P., Devi, L.A., Mackie, K., 2007. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol. Sci. 28, 83-92.
20. Kathuria, S., Gaetani, S., Fegley, D., Valino, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., La Rana, G., Calignano, A., Giustino, A., Tattoli, M., Palmery, M., Cuomo, V., Piomelli, D., 2003. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 9, 76-81.
21. Kearn, C.S., Greenberg, M.J., DiCamelli, R., Kurzawa, K., Hillard, C.J., 1999. Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange. J. Neurochem. 72, 2379-2387.
22. Laviola, G., Macrì, S., Morley-Fletcher, S., Adriani, W., 2003. Risk-taking behavior in adolescent mice: psycho-biological determinants and early epigenetic influence. Neurosci. Biobehav. Rev. 19-31.
23. Laviolette, S.R., Grace, A.A., 2006. The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. Cell. Mol. Life Sci. 63, 1597-1613.
24. Lupica, C.R., Riegel, A.C., Hoffman, A.F., 2004. Marijuana and cannabinoid regulation of brain reward circuits. Br. J. Pharmacol. 143, 227-234.
25. Mackie, K., 2005. Distribution of cannabinoid receptors in the central and peripheral nervous system. In: Pertwee, R.G. (Ed.), Cannabinoids. Handbook of Experimental Pharmacology, Vol.168. Springer, Berlin, pp. 299-323.
26. Marco, E.M., Adriani, W., Canese, R., Podo, F., Viveros, M.P., Laviola, G., 2007. Enhancement of endocannabinoid signalling during adolescence: modulation of impulsivity and long-term consequencesonmetabolic brainparameters inearlymaternally deprived rats. Pharmacol. Biochem. Behav. 86, 334-345.
27. Mato, S., Del Olmo, E., Pazos, A., 2003. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur. J. Neurosci. 17, 1747-1754.
28. McKinney, M.K., Cravatt, B.F., 2005. Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem. 74, 411-432.
29. Melis, M., Pistis, M., Perra, S., Muntoni, A.L., Pillolla, G., Gessa, G.L., 2004. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci. 24, 53-62.
30. Mendiguren, A., Pineda, J., 2007. CB(1) cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices. Neuropharmacology 52, 617-625.
31. Muntoni, A.L., Pillolla, G., Melis, M., Perra, S., Gessa, G.L., Pistis, M., 2006. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. Eur. J. Neurosci. 23, 2385-2394.
32. O'Shea, M., McGregor, I.S., Mallet, P.E., 2006. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. J. Psychopharmacol. 20, 611-621.
33. O'Sullivan, S.E., 2007. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br. J. Pharmacol. 152, 576-582.
34. Onaivi, E.S., Ishiguro, H., Gong, J.P., Patel, S., Perchuk, A., Meozzi, P.A., Myers, L., Mora, Z., Tagliaferro, P., Gardner, E., Brusco, A., Akinshola, B.E., Liu, Q.R., Hope, B., Iwasaki, S., Arinami, T., Teasenfitz, L., Uhl, G.R., 2006. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann. N.Y. Acad. Sci. 1074, 514-536.
35. Oropeza, V.C., Mackie, K., Van Bockstaele, E.J., 2007. Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res. 1127, 36-44.
36. Paxinos, G., Watson, C., 1986. The Rat brain in Stereotaxic Coordinates. Academic Press, San Diego.
37. Pertwee, R.G., 2008. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict. Biol. 13, 147-159.
38. Piomelli, D., 2003. The molecular logic of endocannabinoid signalling. Nat. Rev., Neurosci. 4, 873-884.
39. Piomelli, D., Tarzia, G., Duranti, A., Tontini, A., Mor, M., Compton, T.R., Dasse, O., Monaghan, E.P., Parrott, J.A., Putman, D., 2006. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev. 12, 21-38.
40. Pistis, M., Perra, S., Pillolla, G., Melis, M., Muntoni, A.L., Gessa, G.L., 2004. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol. Psychiatry 56, 86-94.
41. Rice, D., Barone Jr., S., 2000. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108 (Suppl 3), 511-533.
42. Rodriguez de Fonseca, F., Ramos, J.A., Bonnin, A., Fernandez-Ruiz, J.J., 1993. Presence of cannabinoid binding sites in the brain from early postnatal ages. NeuroReport 4, 135-138.
43. Romero, J., Garcia-Palomero, E., Berrendero, F., Garcia-Gil, L., Hernandez, M.L., Ramos, J.A., Fernandez-Ruiz, J.J., 1997.Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse 26, 317-323.
44. Romero, J., Berrendero, F., Manzanares, J., Perez, A., Corchero, J., Fuentes, J.A., Fernandez-Ruiz, J.J., Ramos, J.A., 1998. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol. Synapse 30, 298-308.
45. Rubino, T., Parolaro, D., 2008. Long lasting consequences of cannabis exposure in adolescence. Mol. Cell. Endocrinol. 286, S108-S113.
46. Rubino, T., Vigano, D., Massi, P., Parolaro, D., 2000. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940. J. Neurochem. 75, 2080-2086.
47. Rubino, T., Vigano, D., Realini, N., Guidali, C., Braida, D., Capurro, V., Castiglioni, C., Cherubino, F., Romualdi, P., Candeletti, S., Sala, M., Parolaro, D., 2008. Chronic delta(9)-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology 33, 2760-2771.
48. Saario, S.M., Laitinen, J.T., 2007. Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors. Basic Clin. Pharmacol. Toxicol. 101, 287-293.
49. Schneider, M., Schomig, E., Leweke, F.M., 2008. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. Addict. Biol. 13, 345-357.
50. Sim-Selley, L.J., Schechter, N.S., Rorrer, W.K., Dalton, G.D., Hernandez, J., Martin, B.R., Selley, D.E., 2006. Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration. Mol. Pharmacol. 70, 986-996.
51. Spear, L.P., 2004. Adolescent brain development and animal models. Ann. N.Y. Acad. Sci. 1021, 23-26.
52. Starowicz, K., Nigam, S., Di Marzo, V., 2007. Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther. 114, 13-33.
53. Szabo, B., Siemes, S., Wallmichrath, I., 2002. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur. J. Neurosci. 15, 2057-2061.
54. Thompson, B.L., Stanwood, G.D., in press. Pleiotropic effects of neurotransmission during development: modulators of modularity. J.Autism Dev. Disord. doi:10.1007/s10803-008-0624-0.
55. Vigh, J., von Gersdorff, H., 2007. Endocannabinoids mediate synaptic plasticity at mixed synapses. Neuron 56, 945-946.
56. Vitalis, T., Laine, J., Simon, A., Roland, A., Leterrier, C., Lenkei, Z., 2008. The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro. Eur. J. Neurosci. 28, 1705-1718.
57. Vlachou, S., Nomikos, G.G., Panagis, G., 2006. Effects of endocannabinoid neurotransmission modulators on brainstimulation reward. Psychopharmacology (Berl) 188, 293-305.
58. Watson, S., Chambers, D., Hobbs, C., Doherty, P., Graham, A., 2008. The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation. Mol. Cell. Neurosci. 38, 89-97.